Liquichek Urine Toxicology Control, Levels C2 Low Opiate and C3 Low Opiate

Image
qsd_c23lo_pdp.jpg

Overview

Human urine controls containing drugs of abuse or their metabolites at concentrations 20–25% above or below confirmatory cutoff levels with 300 ng/mL Opiate cutoff
Read full description Ordering Information

Description

Description

Liquichek Urine Toxicology Control, Levels C2 Low Opiate & C3 Low Opiate, is prepared from human urine containing added drugs of abuse or their metabolites at concentrations 20–25% above or below confirmatory cutoff levels.

  • 3 year shelf life at 2–8°C
  • 30 day open-vial stability at 2–8°C
  • 300 ng/mL Opiate cutoff

Refer to the package insert for current analyte claims.

Gravimetric Reference Values

      ↓   Designed for SAMHSA* Cutoff   ↓    
Analytes (ng/mL) Level C1 Level C2 Level C3 Level C4 Level C2
Low
Opiate
Level C3
Low
Opiate
d-Amphetamine
d-Methamphetamine
3, 4-Methylenedioxymethamphetamine (MDMA)
3, 4-Methylenedioxyamphetamine (MDA)
3, 4-Methylenedioxy-N-ethylamphetamine (MDEA)
100
100
100
100
100
188
188
188
188
188
312
312
312
312
312
750
750
750
750
750
375
375


625
625


Amobarbitital
Butalbital
Pentobarbital
Phenobarbitital
Secobarbital
80
80
80
80
80
150
150
150
150
150
250
250
250
250
250
1,200
1,200
1,200
1,200
1,200
150
150
150
150
150
250
250
250
250
250
Alpha-Hydroxyalprazolam
Nordiazepam
Oxazepam +
80
80
+
225
225
+
375
375
+
1,000
1,000
+
225
225
+
375
375
+
11-Nor-Δ-9-THC-9-COOH 6 11.5 18.5 150 11.5 18.5
Benzoylecgonine 40 75 125 300 115 185
Ethanol (mg/dL) 20 40 70 250 40 70
Lysergic Acid Diethylamide (LSD) 0.2 0.35 0.65 4.0 0.35 0.65
Methadone
EDDP (Methadone Metabolite) +
120
+
225
+
375
+
1,000
+
225
+
375
+
Methaqualone 120 225 375 1,000 225 375
6-Monoacetylmorphine +
Codeine
Morphine-3-β-d-Glucuronide
+
120
120
+
1,500
1,500
+
2,500
2,500
+
4,000
4,000
+
225
225
+
375
375
Phencyclidine (PCP) 10 19 31 100 19 31
Propoxyphene
Norpropoxyphene
120
120
225
225
375
375
1,000
1,000
225
225
375
375

Analyte present, no claims made regarding performance or stability.
United States Substance Abuse and Mental Health Services Administration.

Ordering

Ordering

items

Use the filters below to refine results!

Image
468_qsd_c2lo_tn.jpg
468
Liquid human urine control with drugs of abuse at 20–25% below cutoff levels; for 300 ng/mL Opiate cutoff (10 x 20 mL)
Image
469_qsd_c3lo_tn.jpg
469
Liquid human urine control with drugs of abuse at 20–25% above cutoff levels; for 300 ng/mL Opiate cutoff (10 x 20 mL)
Image
468x_c2lo_tn.jpg
468X
Liquid human urine control with drugs of abuse at 20–25% below cutoff levels; for 300 ng/mL Opiate cutoff; MiniPak (1 x 20 mL)
Image
469x_c3lo_tn.jpg
469X
Liquid human urine control with drugs of abuse at 20–25% above cutoff levels; for 300 ng/mL Opiate cutoff; MiniPak (1 x 20 mL)
Image
460_qsd_utneg_tn.jpg
460
Liquid human urine negative control confirmed negative at the specified detection limits for over 30 drugs of abuse (10 x 20 mL)
Image
460x_utneg_tn.jpg
460X
Liquid human urine negative control confirmed negative at the specified detection limits for over 30 drugs of abuse; MiniPak (1 x 20 mL)

Accessories

Accessories

Image
qsd_588_tip_crimpcap_tn.jpg
588
Disposable plastic tip accessory to enable fluid delivery directly from glass vials supplied with a metal crimp seal and stopper. 50/Package

Documents

Documents

Number Description Options
Q-1551
Urine Toxicology Controls
[ Add to Cart (Free) ]
Q-1118
Quality Control Products & Services Catalog
[ Add to Cart (Free) ]